New York, NY
Joined April 2019
Hybrid dinner #Cushing's CME in Atlanta & online, free registration, panel discussions chaired by @MariaFleseriu & talks by #RichAuchus, @IrinaBancos @EBGeerMD cmmregistration.com/ Feeling Better After Feeling Worse:Navigating Patients through the Cortisol Withdrawal Syndrome
1
4
Very challenging cases facing this international panel during our annual #pituitary course today. ⁦@MSKNeurosurgery⁩
2
5
⁦@GeraldRaverot⁩ discussing very eloquently the challenging topic of aggressive #pituitary tumors at our annual #MSKpituitaryCME @MSKNeurosurgery meeting. Large audience and great engagement from the #pituitary community!
2
3
#Cushing’s disease is a serious illness that challenges patients and doctors alike.
This Post is from an account that no longer exists. Learn more
Our annual rendez-vous with #pituitarytumor patients doctors nurses and APP is coming up on 4/9. Exciting program #Cushing’s disease #acromegaly, surgery, expert speakers @EBGeerMD @MSKNeurosurgery @JunMaoMD @GeraldRaverot. Join us mskcc.cloud-cme.com/course/c…
3
3
Join our team of MSK Experts 4/9 for an update on the treatment of #PituitaryTumors. This course is not only for medical professionals but patients and caregivers as well. Learn more below. #RareDiseaseDay @pituitaryorg @CSRFnet @MSKNeurosurgery bit.ly/3v0Poaj
6
2
11
Tomorrow is #RareDiseaseDay. Did you know, many endocrine conditions are rare diseases. #AddisonsDisease is just one. Learn more about it and other endocrine disorders.@AddisonsUK @adrenalnetwork yourhormones.info/endocrine-…
2
17
45
In this #CME activity, @EBGeerMD & @cme_doc discuss treatment goals & algorithms for the medical management of #CushingsDisease. Join the conversation: bit.ly/3LKq4Lu #MedEd
2
4
Today is #CushingsAwarenessDay! Let's raise awareness 🙌 #ThinkCushings 📃 We will be sharing resources and stories throughout the day 🗨️ This is also a great chance to share your personal experiences. Use #CushingsAwarenessDay and tag us in too!
4
13
Join us now for a great discussion on #acromegaly, recordings starting soon and then live discussion! Looking forward "chatting" with you! #ENDO2021 @PituitarySoc
2
3
9
#ENDO2021 Join @EBGeerMD @MariaFleseriu & Adriana Ioachimescu MD, PhD Sunday, March 21st for "Acromegaly: Novel Therapeutic Options to Alleviate Treatment Burden and Improve Patient Quality of Life" at 5:30 PM ET. Register today >> ow.ly/2rMC50DxOtl
6
11
Eliza B Geer retweeted
Early Rate ends tomorrow for our #MSKpituitaryCME course on Sat., Dec 5 @sloan_kettering! Stay up-to-date on the latest developments in ongoing basic & translational science of patients w/ #pituitary diseases including #cushings & #acromegaly. Register: bit.ly/2ZKOezka
1
4
6
Eliza B Geer retweeted
Replying to @CSRFnet
@CSRFnet @Acrocommunity @pituitaryorg will lead a discussion on treatment & new therapy options for #cushings, #pituitary, & #acromegaly #patients at our #MSKpituitaryCME course. Complimentary registration for patients & caregivers: bit.ly/2ZKOezk
2
2
Great collaboration , always a pleasure to work with you , Andrea and let’s not forget that the #consensus meetings are the highlight of the year for all of us! #acromegaly @AcroCommunity @PituitaryWNews
Just out in #REMD the last consensus on #multimodal management of #acromegaly rdcu.be/b63aB including the brand new therapeutic algorithm! Fantastic team effort from an incredible group of great experts and friends! Thank you ALL for the superb contribution!!
1
3
6
⁣New Horizons for Medical Management of #Acromegaly on Thursday, Sept. 10 | Attend a complimentary presentation with case-based learning, presented by Drs. Shlomo Melmed @MelmedShlomo, Eliza B. Geer @EBGeerMD, and Laurence Katznelson. Register now: bit.ly/2QNSs4j⠀
6
1
11
Eliza B Geer retweeted
We're excited to invite #providers, #patients & #caregivers to learn & connect w/ experts & each other at our Live Virtual 2020 Update on the Treatment of #Pituitary Tumors: Emerging Therapies course on Dec 5th @sloan_kettering. CME& ABIM MOC Accredited: bit.ly/2OjyJIj.
5
9
Our clinical trial for aggressive #pituitary tumors @MSKNeurosurgery is accruing, using ipilimumab and nivolumab #Immunotherapy (NCT04042753). Leading the way in novel therapy for #pituitarytumors @TheEndoSociety @NeuroOnc @AANSNeuro @CNS_Update @NASBSorg
7
17